Achilles Therapeutics
PITCH
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens: protein markers unique to each individual that are present on the surface of a cancer cell and can be detected by the immune system.
LATEST INVESTMENT
#BioPharma
11.2020
Achilles Therapeutics
£52.7M
OrbiMed, Boxer Capital, RA Capital, Syncona, Forbion, Invus, Perceptive Advisors & Redmile Group